References
- Abraham NS, Hlatky MA, Antman EM, et al (2010). ACCF/ACG/AHA 2010 expert consensus document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use. Am J Gastroenterol, 105, 2533-49. https://doi.org/10.1038/ajg.2010.445
- Alahdab YO, Kalayci C (2014). Helicobacter pylori : Management in 2013. World J Gastroenterol, 20, 5302-7. https://doi.org/10.3748/wjg.v20.i18.5302
- Arkkila PE, Seppala K, Kosunen TU, et al (2005). Helicobacter pylori eradication as the sole treatment for gastric and duodenal ulcers. Eur J Gastroenterol Hepatol, 17, 93-101. https://doi.org/10.1097/00042737-200501000-00018
- Asaka M, Kato M, Graham DY (2010). Prevention of gastric cancer by Helicobacter pylori eradication. Intern Med, 49, 633-6. https://doi.org/10.2169/internalmedicine.49.3470
- Asaka M, Sugiyama T, Nobuta A, et al (2001). Atrophic gastritis and intestinal metaplasia in Japan: results of a large multicenter study. Helicobacter, 6, 294-9. https://doi.org/10.1046/j.1523-5378.2001.00042.x
- Bravo LE, Realpe JL, Campo C, et al (1999). Effects of acid suppression and bismuth medications on the performance of diagnostic tests for Helicobacter pylori infection. Am J Gastroenterol, 94, 2380-3. https://doi.org/10.1111/j.1572-0241.1999.01361.x
- Burucoa C, Delchier JC, Courillon-Mallet A, et al (2013). Comparative evaluation of 29 commercial Helicobacter pylori serological kits. Helicobacter, 18, 169-79. https://doi.org/10.1111/hel.12030
- Cammarota G, Martino A, Pirozza G, et al (2004). High efficacy of 1-week doxycyline- and amoxicillin-based quadruple regimen in a culture-guided, third-line treatment approach for H. pylori infection. Aliment Pharmacol Ther, 19, 789-95. https://doi.org/10.1111/j.1365-2036.2004.01910.x
- Chan FK, Ching JY, Suen BY, et al (2013). Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users. Gastroenterol, 144, 528-35. https://doi.org/10.1053/j.gastro.2012.12.038
- Chan FK, Sung JJ, Chung SC, et al (1997). Randomised trial of eradication of Helicobacter pylori before non-steroidal anti-inflammatory drug therapy to prevent peptic ulcers. Lancet, 350, 975-9. https://doi.org/10.1016/S0140-6736(97)04523-6
- Chan FK, To KF, Wu JC, et al (2002). Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial. Lancet, 359, 9-13. https://doi.org/10.1016/S0140-6736(02)07272-0
- Chen HN, Wang Z, Li X et al (2016). Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Gastric Cancer.
- Chen LT, Lin JT, Tai JJ, et al (2005). Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J Natl Cancer Inst, 97, 1345-53. https://doi.org/10.1093/jnci/dji277
- Chey WD, Wong BC (2007). Practice parameters committee of the american college of gastroenterology. american college of gastroenterology guideline on the management of Helicobacter pylori infection. Am J Gastroenterol, 102, 1808. https://doi.org/10.1111/j.1572-0241.2007.01393.x
- Chitapanarux T, Thongsawat S, et al (2015). Effect of Bifidobacterium longum on-based triple PPI therapy for eradication of Helicobacter pylori. Functional Foods, 13, 289-94. https://doi.org/10.1016/j.jff.2015.01.003
- Chung JW, Lee JH, Jung HY, et al (2011). Second-line Helicobacter pylori eradication: a randomized comparison of 1 week or 2 week bismuth-containing quadruple therapy. Helicobacter, 16, 289-94. https://doi.org/10.1111/j.1523-5378.2011.00844.x
- Chung SJ, Lim SH, Choi J, et al (2011). Helicobacter pylori serology inversely correlated with the risk and severity of reflux esophagitis in Helicobacter pylori endemic Area: A matched case-control study of 5,616 health check-up Koreans. J Neurogastroenterol Motil, 17, 267-73. https://doi.org/10.5056/jnm.2011.17.3.267
- Correa P (1992). Human gastric carcinogenesis: a multistep and multifactorial process--first american cancer society award lecture on cancer epidemiology and prevention. Cancer Res, 52, 6735-40.
- Correa P, Piazuelo MB, Wilson KT (2010). Pathology of gastric intestinal metaplasia: clinical implications. Am J Gastroenterol, 105, 493-8. https://doi.org/10.1038/ajg.2009.728
- Crowe SE (2015). Indications and diagnostic tests for Helicobacter pylori infection. Up To Date. Literature review current through: Jul 2015. | This topic last updated: Mar 12, 2015.
- Cutler AF, Elnagger M, Brooks E, et al (1998). Effect of standard and high dose ranitidine on [13C] urea breath test results. Am J Gastroenterol, 93, 1297-99. https://doi.org/10.1111/j.1572-0241.1998.00412.x
- Cutler AF, Prasad VM, Santogade P (1998). Four-year trends in Helicobacter pylori IgG serology following successful eradication. Am J Med, 105, 18. https://doi.org/10.1016/S0002-9343(98)00134-X
- de Vries AC, van Grieken NC, Looman CW, et al (2008). Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterol, 134, 945-52. https://doi.org/10.1053/j.gastro.2008.01.071
- Di Caro S, Fini L, Daoud Y, et al (2012). Levofloxacin/amoxicillin-based schemes vs quadruple therapy for Helicobacter pylori eradication in second line: a systematic review. World J Gastroenterol, 18, 5669-78. https://doi.org/10.3748/wjg.v18.i40.5669
- Dinis-Ribeiro M, Areia M, de Vries AC et al (2012). Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED). Endoscopy, 44, 74-94. https://doi.org/10.1055/s-0031-1291491
- Dinis-Ribeiro M, Lopes C, da Costa-Pereira A, et al (2004). A follow up model for patients with atrophic chronic gastritis and intestinal metaplasia. J Clin Pathol, 57, 177-82. https://doi.org/10.1136/jcp.2003.11270
- Federico A, Nardone G, Gravina AG, et al (2012). Efficacy of 5-day levofloxacin-containing concomitant therapy in eradication of Helicobacter pylori infection. Gastroenterol, 143, 55-61. https://doi.org/10.1053/j.gastro.2012.03.043
- Fischbach L, Evans EL (2007). Meta-analysis: the effect of antibiotic resistance status on the efficacy of triple and quadruple first-line therapies for Helicobacter pylori. Aliment Pharmacol Ther, 26, 343-57. https://doi.org/10.1111/j.1365-2036.2007.03386.x
- Fischbach LA, Graham DY, Kramer JR, et al (2014). Association between Helicobacter pylori and Barrett's esophagus: a case-control study. Am J Gastroenterol, 109, 357-68. https://doi.org/10.1038/ajg.2013.443
- Figura N, Crabtree JE, Dattilo M (1997). In-vitro activity of lansoprazole against Helicobacter pylori. J Antimicrob Chemother, 39, 585-90. https://doi.org/10.1093/jac/39.5.585
- Ford AC, Delaney BC, Forman D, et al (2004). Eradication therapy in Helicobacter pylori positive peptic ulcer disease: systematic review and economic analysis. Am J Gastroenterol, 99, 1833-55. https://doi.org/10.1111/j.1572-0241.2004.40014.x
- Ford AC, Delaney BC, Forman D, et al (2006). Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients. Cochrane Database Syst Rev.
- Ford AC, Forman D, Hunt RH, et al (2014). Helicobacter pylori eradication therapy to prevent gastric cancer in healthy asymptomatic infected individuals: systematic review and meta-analysis of randomised controlled trials. BMJ, 348, 3174. https://doi.org/10.1136/bmj.g3174
- Franceschi FL, Cazzato A, et al (2007). A Role of probiotics in patients with Helicobacter pylori infection. Helicobacter, 12, 59-63. https://doi.org/10.1111/j.1523-5378.2007.00565.x
- Fuccio L, Zagari RM, Eusebi LH, et al (2009). Meta-analysis: can Helicobacter pylori eradication treatment reduce the risk for gastric cancer? Ann Intern Med, 151, 121-8. https://doi.org/10.7326/0003-4819-151-2-200907210-00009
- Fukase K, Kato M, Kikuchi S, et al (2008). Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet, 372, 392-7. https://doi.org/10.1016/S0140-6736(08)61159-9
- Gatta L, Vakil N, Ricci C, et al (2004). Effect of proton pump inhibitors and antacid therapy on 13C-urea breath tests and stool test for Helicobacter pylori infection. Am J Gastroenterol, 99, 823-9. https://doi.org/10.1111/j.1572-0241.2004.30162.x
- Gisbert JP, Barrio J, Modolell I, et al (2015). Helicobacter pylori first-line and rescue treatment in the presence of penicillin allergy. Dig Dis Sci, 60, 458-64. https://doi.org/10.1007/s10620-014-3365-2
- Gisbert JP, Khorrami S, Carballo F, et al (2004). H. pylori eradication therapy vs. antisecretory non-eradication therapy (with or without long-term maintenance antisecretory therapy) for the prevention of recurrent bleeding from peptic ulcer. Cochrane Database Syst Rev. 4062.
- Gisbert JP, Gisbert JL, Marcos S, et al (2005). Helicobacter pylori first-line treatment and rescue options in patients allergic to penicillin. Aliment Pharmacol Ther, 22, 1041-6. https://doi.org/10.1111/j.1365-2036.2005.02687.x
- Gisbert JP, Pajares JM (2005). Review article: C-urea breath test in the management of Helicobacter pylori infection: Review article. Diagnosis Liver Disease, 37, 899-906. https://doi.org/10.1016/j.dld.2005.09.006
- Gisbert JP, Pajares JM (2005). Systematic review and meta-analysis: is 1-week proton pump inhibitor-based triple therapy sufficient to heal peptic ulcer? Aliment Pharmacol Ther, 21, 795-804. https://doi.org/10.1111/j.1365-2036.2005.02418.x
- Goddard AF, Badreldin R, Pritchard DM et al (2010). The management of gastric polyps. Gut, 59, 1270-6. https://doi.org/10.1136/gut.2009.182089
- Graham DY, Hammoud F, El-Zimaity HM, et al (2003). Meta-analysis: proton pump inhibitor or H2-receptor antagonist for Helicobacter pylori eradication. Aliment Pharmacol Ther, 17, 1229-36. https://doi.org/10.1046/j.1365-2036.2003.01583.x
- Graham DY, Klein PD (2000). Accurate diagnosis of Helicobacter pylori. 13C-urea breath test. Gastroenterol Clin North Am, 29, 885-93. https://doi.org/10.1016/S0889-8553(05)70156-4
- Graham DY, Opekun AR, Hammoud F, et al (2003). Studies regarding the mechanism of false negative urea breath tests with proton pump inhibitors. Am J Gastroenterol, 98, 1005-9. https://doi.org/10.1111/j.1572-0241.2003.07426.x
- Hackelsberger A, Schultze V, Gunther T, et al (1997). Helicobacter pylori prevalence in reflux esophagitis: A case control study (abstract). Gastroenterol, 112, A137.
- Higuchi K, Fujiwara Y, Tominaga K, et al (2003). Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study. Aliment Pharmacol Ther, 17, 111-17.
- Howden CW, Hunt RH (1998). Guidelines for the management of Helicobacter pylori infection. ad hoc committee on practice parameters of the american college of gastroenterology. Am J Gastroenterol, 93, 2330-8. https://doi.org/10.1111/j.1572-0241.1998.00684.x
- Hong SS, Jung HY, Choi KD, et al (2006). A prospective analysis of low-grade gastric malt lymphoma after Helicobacter pylori eradication. Helicobacter, 11, 569-73. https://doi.org/10.1111/j.1523-5378.2006.00460.x
- Huang JQ, Sridhar S, Hunt RH (2002). Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic-ulcer disease: a meta-analysis. Lancet, 359, 14-22. https://doi.org/10.1016/S0140-6736(02)07273-2
- Jainan W, Vilaichone RK (2014). Effects of the CYP2C19 genetic polymorphism on gastritis, peptic ulcer disease, peptic ulcer bleeding and gastric cancer. Asian Pac J Cancer Prev, 15, 10957-60.
- Jeajaroonwong W (2003). PPI-based Triple Therapy for Helicobacter pylori Eradication at NaKhonpathom Hospital. Reg 4-5 Med J, 31, 14-8.
- Jyotheeswaran S, Shah AN, Jin HO, et al (1998). Prevalence of Helicobacter pylori in peptic ulcer patients in greater Rochester, NY: is empirical triple therapy justified? Am J Gastroenterol, 93, 574. https://doi.org/10.1111/j.1572-0241.1998.167_b.x
- Kanizaj TF, Kunac N (2014). Helicobacter pylori: future perspectives in therapy reflecting three decades of experience. World J Gastroenterol, 20, 699-705. https://doi.org/10.3748/wjg.v20.i3.699
- Kato M, Asaka M, Ono S, et al (2007). Eradication of Helicobacter pylori for primary gastric cancer and secondary gastric cancer after endoscopic mucosal resection. J Gastroenterol, 42, 16-20.
- Kim SG, Jung HK, Lee HL, et al (2014). Guidelines for the diagnosis and treatment of Helicobacter pylori infection in Korea, 2013 revised edition. J Gastroenterol Hepatol, 29, 1371-86. https://doi.org/10.1111/jgh.12607
- Kongchayanun C, Vilaichone R, Pornthisarn B, et al (2012). Pilot studies to identify the optimum duration of concomitant helicobacter pylori eradication therapy in Thailand. Helicobacter, 17, 282-5. https://doi.org/10.1111/j.1523-5378.2012.00953.x
- Kullavanijaya P, Thong-Ngam D, Hanvivatvong O, et al (2004). Analysis of eight different methods for the detection of Helicobacter pylori infection in patients with dyspepsia. J Gastroenterol Hepatol, 19, 1392-6. https://doi.org/10.1111/j.1440-1746.2004.03506.x
- Laine L, Estrada R, Trujillo M, et al (1998). Effect of proton-pump inhibitor therapy on diagnostic testing for Helicobacter pylori. Ann Intern Med, 129, 547. https://doi.org/10.7326/0003-4819-129-7-199810010-00007
- Laine L, Hopkins RJ, Girardi LS (1998). Has the impact of Helicobacter pylori therapy on ulcer recurrence in the United States been overstated? A meta-analysis of rigorously designed trials. Am J Gastroenterol, 93, 1409.
- Lamouliatte H, Megraud F, Delchier J, et al (2003). Second-line treatment for failure toeradicate H. pylori: a randomized trial comparing four treatment strategies. Aliment Pharmacol Ther, 18, 791-7. https://doi.org/10.1046/j.1365-2036.2003.01759.x
- Lam SK, Ching CK, Lai KC, et al (1997). Does treatment of Helicobacter pylori with antibiotics alone heal duodenal ulcer? A randomized double blind placebo controlled study. Gut, 41, 43. https://doi.org/10.1136/gut.41.1.43
- Leodoltor A, Dominguez-Munoz JE, von Arnim U, et al (1999). Validity of a modified 13 C-urea breath test for pre-and posttreatment diagnosis of Helicobacter pylori in the routine clinical setting. Am J Gastroenterol, 94, 2100-4. https://doi.org/10.1111/j.1572-0241.1999.01284.x
- Leodolter A, Kulig M, Brasch H, et al (2001). A meta-analysis comparing eradication, healing and relapse rates in patients with Helicobacter pylori-associated gastric or duodenal ulcer. Aliment Pharmacol Ther, 15, 1949. https://doi.org/10.1046/j.1365-2036.2001.01109.x
- Leung WK, Lin SR, Ching JY et al (2004). Factors predicting progression of gastric intestinal metaplasia: results of a randomised trial on Helicobacter pylori eradication. Gut, 53, 1244-9. https://doi.org/10.1136/gut.2003.034629
- Loy CT, Irwig LM, Katelaris PH, et al (1996). Do commercial serological kits for Helicobacter pylori infection differ in accuracy? A meta-analysis. Am J Gastroenterol, 91, 1138-44.
- Lundell L, Havu N, Miettinen P, et al (2006). Changes of gastric mucosal architecture during long-term omeprazole therapy: results of a randomized clinical trial. Aliment Pharmacol Ther, 23, 639-47. https://doi.org/10.1111/j.1365-2036.2006.02792.x
- Lundell L, Vieth M, Gibson F, et al (2015). Systematic review: the effects of long-term proton pump inhibitor use on serum gastrin levels and gastric histology. Aliment Pharmacol Ther, 42, 649-63. https://doi.org/10.1111/apt.13324
- Mahachai V, Vilaichone RK (2011). Current status of Helicobacter pylori Infection in Thailand. Helicobacter Research, 15, 38-44.
- Maehata Y, Nakamura S, Fujisawa K, et al (2012). Long-term effect of Helicobacter pylori eradication on the development of metachronous gastric cancer after endoscopic resection of early gastric cancer. Gastrointest Endosc, 75, 39-46. https://doi.org/10.1016/j.gie.2011.08.030
- Malfertheiner P, Megraud F, O'Morain CA, et al (2012). Management of Helicobacter pylori infection--the maastricht iv/ florence consensus report. Gut, 61, 646-64. https://doi.org/10.1136/gutjnl-2012-302084
- Marzio L, Cellini L, Angelucci D (2003). Triple therapy for 7 days vs. triple therapy for 7 days plus omeprazole for 21 days in treatment of active duodenal ulcer with Helicobacter pylori infection. A double blind placebo controlled trial. Dig Liver Dis, 35, 20e3.
- Moayyedi P (2011). Helicobacter pylori eradication for functional dyspepsia: what are we treating?: comment on "Helicobacter pylori eradication in functional dyspepsia". Arch Intern Med, 171, 1936-7. https://doi.org/10.1001/archinternmed.2011.541
- Moayyedi P, Soo S, Deeks J, et al (2000). Systematic review and economic evaluation of Helicobacter pylori eradication treatment for non-ulcer dyspepsia. Dyspepsia Review Group. BMJ, 321, 659-64. https://doi.org/10.1136/bmj.321.7262.659
- Moayyedi P, Wason C, Peacock R, et al (2000). Changing patterns of Helicobacter pylori gastritis in long-standing acid suppression. Helicobacter, 5, 2016-14.
- O'Connor HJ (1999). Review article: Helicobacter pylori and gastro-oesophageal reflux disease-clinical implications and management. Aliment Pharmacol Ther, 13, 117-27. https://doi.org/10.1046/j.1365-2036.1999.00460.x
- Patel SK, Pratap CB, Jain AK, et al (2014). Diagnosis of Helicobacter pylori: what should be the gold standard? World J Gastroenterol, 20, 12847-59. https://doi.org/10.3748/wjg.v20.i36.12847
- Perri F, Manes G, Neri M, et al (2002). Helicobacter pylori antigen stool test and 13C-urea breath test in patients after eradication treatments. Am J Gastroenterol, 97, 2756. https://doi.org/10.1111/j.1572-0241.2002.07065.x
- Pittayanon R, Vilaichone RK, Lee GH, et al (2015). Influences of duration of treatment, CYP2C19 genotyping, interleukin-1 polymorphisms and antibiotic resistant strains in Helicobacter pylori eradication rates. digestive disease week (DDW), Washinton DC, USA (Abstract).
- Prapitpaiboon H, Mahachai V, Vilaichone RK (2015). High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand. Asian Pac J Cancer Prev, 16, 4353-6. https://doi.org/10.7314/APJCP.2015.16.10.4353
- Prasertpetmanee S, Mahachai V, Vilaichone RK (2013). Improved efficacy of PPI - amoxicillin - clarithromycin triple therapy for H. pylori eradication in low clarithromycin resistance areas or for tailored therapy. Helicobacter, 18, 270-3. https://doi.org/10.1111/hel.12041
- Rokkas T, Sechopoulos P, Pistiolas D, et al (2010). Helicobacter pylori infection and gastric histology in first-degree relatives of gastric cancer patients: a meta-analysis. Eur J Gastroenterol Hepatol, 22, 1128-33. https://doi.org/10.1097/MEG.0b013e3283398d37
- Romano M, Cuomo A, Gravina AG, et al (2010). Empiric levofloxacin-containing vs clarithromycin-containing sequential therapy for Helicobacter pylori eradication: a randomized trial. Gut, 59, 1465-70. https://doi.org/10.1136/gut.2010.215350
- Ruskone-Fourmestraux A, Fischbach W, Aleman BM, et al (2011). EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT. Gut, 60, 747-58. https://doi.org/10.1136/gut.2010.224949
- Savarino V, Tracci D, Dulbecco P, et al (2001). Negative effect of ranitidine on the results of urea breath test for the diagnosis of Helicobacter pylori. Am J Gastroenterol, 96, 348-52. https://doi.org/10.1111/j.1572-0241.2001.03517.x
- Schenk BE, Kuipers EJ, Nelis GF, et al (2000). Effect of Helicobacter pylori eradication on chronic gastritis during omeprazole therapy. Gut, 46, 615-21. https://doi.org/10.1136/gut.46.5.615
- Shirin H, Levine A, Shevah O, et al (2005). Eradication of Helicobacter pylori can be accurately confirmed 14 days after termination of triple therapy using a high-dose citric acid-based 13C urea breath test. Digestion, 71, 208-12. https://doi.org/10.1159/000087045
- Shirota T, Kusano M, Kawamura O, et al (1999). Helicobacter pylori infection correlates with severity of reflux esophagitis: with manometry findings. J Gastroenterol, 34, 553-9. https://doi.org/10.1007/s005350050372
- Sipponen P, Helske T, Jarvinen P et al (1994). Fall in the prevalence of chronic gastritis over 15 years: analysis of outpatient series in Finland from 1977, 1985, and 1992. Gut, 35, 1167-71. https://doi.org/10.1136/gut.35.9.1167
- Sirimontaporn N, Thong-Ngam D, Tumwasorn S, et al (2010). Ten-day Sequential Therapy of Helicobacter pylori infection in Thailand. Am J Gastroenterol, 105, 1071-5. https://doi.org/10.1038/ajg.2009.708
- Smith SM, O'Morain C, McNamara D (2014). Antimicrobial susceptibility testing for Helicobacter pylori in times of increasing antibiotic resistance. World J Gastroenterol, 20, 9912-21. https://doi.org/10.3748/wjg.v20.i29.9912
- Song H, Ekheden IG, Zheng Z, et al (2015). Incidence of gastric cancer among patients with gastric precancerous lesions: observational cohort study in a low risk Western population. BMJ, 351, 3867.
- Srinarong C, Mahachai V, Vilaichone RK (2014). High efficacy of 14-day standard triple therapy plus bismuth with probiotic supplement for H. pylori eradication in low clarithromycin resistance areas. Asian Pac J Cancer Prev, 15, 9909-13. https://doi.org/10.7314/APJCP.2014.15.22.9909
- Stathis A, Chini C, Bertoni F, et al (2009). Long-term outcome following Helicobacter pylori eradication in a retrospective study of 105 patients with localized gastric marginal zone B-cell lymphoma of MALT type. Ann Oncol, 20, 1086-93. https://doi.org/10.1093/annonc/mdn760
- Sugano K, Tack J, Kuipers EJ, et al (2015). Kyoto global consensus report on Helicobacter pylori gastritis. Gut, 64, 1353-67. https://doi.org/10.1136/gutjnl-2015-309252
- Tan J, Wang Y, Sun X, et al (2015). The effect of Helicobacter pylori eradication therapy on the development of gastroesophageal reflux disease. Am J Med Sci, 349, 364-71. https://doi.org/10.1097/MAJ.0000000000000429
- Thailand Consensus for the management of Dyspepsia and Helicobacter pylori 2010 issued by The Gastroenterology Association of Thailand, Krungthep Vechasarn publishing, Bangkok, Thailand
- Uemura N, Okamoto S, Yamamoto S, et al (2001). Helicobacter pylori infection and the development of gastric cancer. N Engl J Med, 345, 784-9. https://doi.org/10.1056/NEJMoa001999
- Vaira D, Malfertheiner P, Megraud F, et al (1999). Diagnosis of Helicobacter pylori infection with a new non-invasive antigen-based assay. HpSA European study group. Lancet, 354, 30-3. https://doi.org/10.1016/S0140-6736(98)08103-3
- Vakil N, Hahn B, McSorley D (2000). Recurrent symptoms and gastroesophageal reflux disease in patients with duodenal ulcer treated for Helicobacter pylori infection. Aliment Pharmacol Ther, 14, 45-51. https://doi.org/10.1046/j.1365-2036.2000.00677.x
- van Zanten SV, van der Knoop B (2008). Gastric ulcer treatment: cure of Helicobacter pylori infection without subsequent acid-suppressive therapy: is it effective? Eur J Gastroenterol Hepatol, 20, 489-91. https://doi.org/10.1097/MEG.0b013e3282f427c8
- Varocha M, Sirimontaporn N, Thong-Ngam D, et al (2011). Sequential therapy in clarithromycin-sensitive and resistant Helicobacter pylori based on polymerase chain reaction molecular test. J Gastroenterol Hepatol, 26, 825-8. https://doi.org/10.1111/j.1440-1746.2011.06660.x
- Vilaichone RK, Mahachai V, Graham DY (2006). Helicobacter pylori: Diagnosis and management. Gastroenterol Clin North Am, 35, 229-47. https://doi.org/10.1016/j.gtc.2006.03.004
- Vergara M, Catalan M, Gisbert JP, et al (2005). Meta-analysis: role of Helicobacter pylori eradication in the prevention of peptic ulcer in NSAID users. Aliment Pharmacol Ther
- Wang C, Yuan Y, Hunt RH (2009). Helicobacter pylori infection and Barrett's esophagus: a systematic review and meta-analysis. Am J Gastroenterol, 104, 492-500. https://doi.org/10.1038/ajg.2008.37
- Wang J, Xu L, Shi R, et al (2011). Gastric atrophy and intestinal metaplasia before and after Helicobacter pylori eradication: a meta-analysis. Digestion, 83, 253-60. https://doi.org/10.1159/000280318
- Wilcox MH, Dent TH, Hunter JO, et al (1996). Accuracy of serology for the diagnosis of Helicobacter pylori infection-a comparison of eight kits. J Clin Pathol, 49, 373-6. https://doi.org/10.1136/jcp.49.5.373
- Wong BC, Lam SK, Wong WM, et al (2004). Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA, 291, 187-94. https://doi.org/10.1001/jama.291.2.187
- Wotherspoon AC, Doglioni C, Diss TC, et al (1993). Regression of primary low-grade B-cell gastric lymphoma of mucosa-associated lymphoid tissue type after eradication of Helicobacter pylori. Lancet, 342, 575-7. https://doi.org/10.1016/0140-6736(93)91409-F
- Zagari RM, Romano M, Ojetti V, et al (2015). Guidelines for the management of Helicobacter pylori infection in Italy: the III working group consensus report 2015. Dig Liver Dis, 47, 903-12. https://doi.org/10.1016/j.dld.2015.06.010
- Zhang MM, Qian W, Qin YY, et al (2015). Probiotics in Helicobacter pylori eradication therapy: a systematic review and meta-analysis. World J Gastroenterol, 21, 4345-57. https://doi.org/10.3748/wjg.v21.i14.4345
- Zullo A, Hassan C, Andriani A, et al (2009). Eradication therapy for Helicobacter pylori in patients with gastric MALT lymphoma: a pooled data analysis. Am J Gastroenterol, 104, 1932-7. https://doi.org/10.1038/ajg.2009.314